What is the recommended dose and schedule of oral vitamin K1 (phytonadione) for reversing warfarin anticoagulation, including adjustments for INR > 3, active bleeding, and super‑warfarin rodenticide exposure?

Vitamin K Dosing for Warfarin Reversal

The dose of vitamin K depends entirely on the INR level and whether bleeding is present: for INR 5–9 without bleeding give oral vitamin K₁ 1–2.5 mg; for INR ≥9 without bleeding give oral vitamin K₁ 3–5 mg; and for life-threatening bleeding give intravenous vitamin K₁ 10 mg by slow infusion over 30 minutes plus prothrombin complex concentrate. 111

Dosing Algorithm Based on Clinical Scenario

INR Elevation Without Bleeding

INR > therapeutic but <5:

• Simply hold or reduce warfarin dose; no vitamin K needed 11
• Resume at lower dose when INR approaches target range 1

INR 5–9 without bleeding:

• Omit 1–2 warfarin doses and give oral vitamin K₁ 1–2.5 mg if the patient has heightened bleeding risk (age ≥65, prior GI bleed, renal insufficiency, anemia, concurrent antiplatelet therapy) 112
• If no bleeding risk factors, simply holding warfarin may suffice 1
• Expect INR reduction within 24 hours; 95% of patients achieve INR <4 within 24 hours with this dose 1

INR ≥9 without bleeding:

• Give oral vitamin K₁ 3–5 mg 1112
• Anticipate INR decline within 24–48 hours 11
• Monitor closely and repeat vitamin K as necessary 11

Active Bleeding Scenarios

INR ≥20 or major bleeding:

• Give intravenous vitamin K₁ 10 mg as slow infusion over 30 minutes (not exceeding 1 mg/minute) 1123
• Must be supplemented with fresh frozen plasma or prothrombin complex concentrate—vitamin K alone does not provide immediate reversal 1123
• Repeat vitamin K every 12 hours if needed 11

Life-threatening bleeding:

• Administer prothrombin complex concentrate plus intravenous vitamin K₁ 10 mg slow infusion 112
• This combination provides immediate factor replacement while vitamin K begins synthesis of new clotting factors 2

Urgent Surgery or Dental Extraction

When rapid reversal needed within 24 hours:

• Give oral vitamin K₁ 2–5 mg 1112
• Additional 1–2 mg can be given if INR remains elevated after 24 hours 111

Route of Administration: Critical Distinctions

Oral route is preferred for non-emergent situations:

• Oral vitamin K₁ is predictably effective and safer than parenteral routes 11
• Produces INR reduction within 18–24 hours 4
• No risk of anaphylaxis unlike IV administration 11

Subcutaneous route should be avoided:

• Produces unpredictable and delayed responses in randomized trials 112
• Not recommended by guidelines 2

Intravenous route reserved for emergencies only:

• Carries risk of anaphylactic reactions 112
• Must be given as slow infusion ≤1 mg/minute over 15–30 minutes in 25–50 mL normal saline 23
• Produces rapid INR decline within 4–6 hours 24

Special Consideration: Super-Warfarin Rodenticide Exposure

Brodifacoum and similar long-acting anticoagulant rodenticides require dramatically higher doses:

• Reported cases require 300–800 mg/day of oral vitamin K₁ for weeks to months 5
• One case required escalation from 300 mg/day to 800 mg/day when INR rebounded to 189 5
• Compliance becomes a major challenge as patients must take 60–160 tablets daily 5
• Duration of therapy may extend 5+ months 5

Common Pitfalls to Avoid

Do not use excessive vitamin K doses unnecessarily:

• High doses (10 mg oral) may cause warfarin resistance for up to one week 11
• For INR 5–9, the 1–2.5 mg dose is sufficient and avoids resistance 16

Do not expect immediate reversal from vitamin K alone:

• Minimum 1–2 hours required for measurable improvement in prothrombin time 3
• Vitamin K does not counteract heparin 3
• In bleeding emergencies, clotting factors must be given concurrently 123

Do not use subcutaneous vitamin K:

• Multiple studies demonstrate unpredictable absorption 112

Monitor INR closely after vitamin K administration:

• Recheck INR at 24 hours after oral vitamin K 112
• For IV vitamin K in bleeding, monitor every 12 hours 11
• Ultra-low doses (0.25–0.5 mg IV) show similar efficacy to 1–2 mg without rebound 7

Onset of Action and Monitoring

Vitamin K begins reversing warfarin immediately:

• Significant INR decrease detectable within 0–4 hours of administration 4
• Higher doses (10 mg) and IV route produce faster reversal 4
• Complete reversal (INR <1.5) achieved in only 14.5% at 24 hours and 41.7% at 48 hours with vitamin K monotherapy 4
• Baseline INR influences rate: higher baseline INR associated with rapid change, lower baseline with complete reversal 4